Do analysts rate TNFA or FOXX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Foxx Development 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend TNFA or EBON?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, TNFA or EBON?

Ebang International has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A Ebang International $6.54M 2.02 -$14.09M N/A N/A

Is TNFA or EBON more profitable?

Ebang International's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets TNF Pharmaceuticals N/A -69.21% -33.98% Ebang International N/A N/A N/A

Do analysts recommend QCLS or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mymd Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, QCLS or TNFA?

Mymd Pharmaceuticals is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mymd Pharmaceuticals N/A N/A -$11.63M -$20.69 N/A TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A

Is QCLS or TNFA more profitable?

TNF Pharmaceuticals' return on equity of -69.21% beat Mymd Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Mymd Pharmaceuticals N/A -91.64% -47.48% TNF Pharmaceuticals N/A -69.21% -33.98%

Do analysts rate TNFA or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is TNFA or AIMD more profitable?

TNF Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. TNF Pharmaceuticals' return on equity of -69.21% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets TNF Pharmaceuticals N/A -69.21% -33.98% Ainos -11,912.10% -217.50% -67.87%

Do analysts recommend AGMH or TNFA?

AGM Group presently has a consensus price target of $5.77, suggesting a potential upside of 485.55%. Given AGM Group's higher probable upside, analysts clearly believe AGM Group is more favorable than TNF Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AGM Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, AGMH or TNFA?

AGM Group has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AGM Group $30.56M 0.10 $560K N/A N/A TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A

Is AGMH or TNFA more profitable?

AGM Group's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets AGM Group N/A N/A N/A TNF Pharmaceuticals N/A -69.21% -33.98%

TNF Pharmaceuticals (TNFA) Competitors

$2.86 -0.03 (-1.04%)

As of 08/13/2026

Compare

TNFA vs. FOXX, EBON, QCLS, AIMD, and AGMH

Should you buy TNF Pharmaceuticals stock or one of its competitors? TNF Pharmaceuticals's main competitors and comparable companies include Foxx Development (FOXX), Ebang International (EBON), Mymd Pharmaceuticals (QCLS), Ainos (AIMD), and AGM Group (AGMH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does TNF Pharmaceuticals compare to Foxx Development?

TNF Pharmaceuticals (NASDAQ:TNFA) and Foxx Development (NASDAQ:FOXX) are both small-cap technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 60.4% of Foxx Development shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 31.6% of Foxx Development shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Foxx Development has higher revenue and earnings than TNF Pharmaceuticals. Foxx Development is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
Foxx Development	$65.92M	0.27	-$9.02M	-$6.87	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Foxx Development	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

TNF Pharmaceuticals has a net margin of 0.00% compared to Foxx Development's net margin of -79.80%. Foxx Development's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
Foxx Development	-79.80%	N/A	-59.35%

TNF Pharmaceuticals has a beta of 2.04, meaning that its stock price is 104% more volatile than the broader market. Comparatively, Foxx Development has a beta of -0.35, meaning that its stock price is 135% less volatile than the broader market.

In the previous week, Foxx Development had 2 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 2 mentions for Foxx Development and 0 mentions for TNF Pharmaceuticals. Foxx Development's average media sentiment score of 1.44 beat TNF Pharmaceuticals' score of 0.00 indicating that Foxx Development is being referred to more favorably in the news media.

Company	Overall Sentiment
TNF Pharmaceuticals	Neutral
Foxx Development	Positive

Summary

Foxx Development beats TNF Pharmaceuticals on 8 of the 12 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Ebang International?

TNF Pharmaceuticals (NASDAQ:TNFA) and Ebang International (NASDAQ:EBON) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 1.1% of Ebang International shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 25.4% of Ebang International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Ebang International had 4 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 4 mentions for Ebang International and 0 mentions for TNF Pharmaceuticals. Ebang International's average media sentiment score of 0.93 beat TNF Pharmaceuticals' score of 0.00 indicating that Ebang International is being referred to more favorably in the news media.

Company	Overall Sentiment
TNF Pharmaceuticals	Neutral
Ebang International	Positive

Ebang International's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
Ebang International	N/A	N/A	N/A

TNF Pharmaceuticals has a beta of 2.04, suggesting that its stock price is 104% more volatile than the broader market. Comparatively, Ebang International has a beta of 3, suggesting that its stock price is 200% more volatile than the broader market.

Ebang International has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
Ebang International	$6.54M	2.02	-$14.09M	N/A	N/A

Summary

Ebang International beats TNF Pharmaceuticals on 8 of the 9 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Mymd Pharmaceuticals?

Mymd Pharmaceuticals (NASDAQ:QCLS) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

Mymd Pharmaceuticals is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mymd Pharmaceuticals	N/A	N/A	-$11.63M	-$20.69	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

9.6% of Mymd Pharmaceuticals shares are held by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are held by institutional investors. 0.9% of Mymd Pharmaceuticals shares are held by company insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Mymd Pharmaceuticals had 3 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 3 mentions for Mymd Pharmaceuticals and 0 mentions for TNF Pharmaceuticals. Mymd Pharmaceuticals' average media sentiment score of 0.81 beat TNF Pharmaceuticals' score of 0.00 indicating that Mymd Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Mymd Pharmaceuticals	Positive
TNF Pharmaceuticals	Neutral

Mymd Pharmaceuticals has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market. Comparatively, TNF Pharmaceuticals has a beta of 2.04, indicating that its stock price is 104% more volatile than the broader market.

TNF Pharmaceuticals' return on equity of -69.21% beat Mymd Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mymd Pharmaceuticals	N/A	-91.64%	-47.48%
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mymd Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Mymd Pharmaceuticals beats TNF Pharmaceuticals on 6 of the 10 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Ainos?

TNF Pharmaceuticals (NASDAQ:TNFA) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 0.5% of TNF Pharmaceuticals shares are owned by insiders. Comparatively, 9.8% of Ainos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Ainos has higher revenue and earnings than TNF Pharmaceuticals. Ainos is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
Ainos	$13.60K	770.98	-$14.77M	-$2.52	N/A

In the previous week, Ainos had 3 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 3 mentions for Ainos and 0 mentions for TNF Pharmaceuticals. Ainos' average media sentiment score of 0.14 beat TNF Pharmaceuticals' score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company	Overall Sentiment
TNF Pharmaceuticals	Neutral
Ainos	Neutral

TNF Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. TNF Pharmaceuticals' return on equity of -69.21% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
Ainos	-11,912.10%	-217.50%	-67.87%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

TNF Pharmaceuticals has a beta of 2.04, indicating that its share price is 104% more volatile than the broader market. Comparatively, Ainos has a beta of 2.46, indicating that its share price is 146% more volatile than the broader market.

Summary

Ainos beats TNF Pharmaceuticals on 7 of the 12 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to AGM Group?

AGM Group (NASDAQ:AGMH) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

In the previous week, AGM Group had 6 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 6 mentions for AGM Group and 0 mentions for TNF Pharmaceuticals. AGM Group's average media sentiment score of 0.44 beat TNF Pharmaceuticals' score of 0.00 indicating that AGM Group is being referred to more favorably in the media.

Company	Overall Sentiment
AGM Group	Neutral
TNF Pharmaceuticals	Neutral

9.6% of TNF Pharmaceuticals shares are held by institutional investors. 34.9% of AGM Group shares are held by company insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AGM Group presently has a consensus price target of $5.77, suggesting a potential upside of 485.55%. Given AGM Group's higher probable upside, analysts clearly believe AGM Group is more favorable than TNF Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AGM Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

AGM Group's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AGM Group	N/A	N/A	N/A
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

AGM Group has a beta of 2.49, suggesting that its stock price is 149% more volatile than the broader market. Comparatively, TNF Pharmaceuticals has a beta of 2.04, suggesting that its stock price is 104% more volatile than the broader market.

AGM Group has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AGM Group	$30.56M	0.10	$560K	N/A	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

Summary

AGM Group beats TNF Pharmaceuticals on 9 of the 10 factors compared between the two stocks.

Get TNF Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TNFA vs. The Competition

Export

Metric	TNF Pharmaceuticals	Technology Hardware, Storage & Peripherals Industry	Technology Sector	NASDAQ Exchange
Market Cap	$5.28M	$113.97B	$30.69B	$13.10B
Dividend Yield	N/A	1.67%	2.73%	10.45%
P/E Ratio	-0.01	32.06	75.53	25.28
Price / Sales	N/A	49.96	602.15	91.83
Price / Cash	N/A	21.73	53.72	50.90
Price / Book	0.01	8.56	9.57	6.24
Net Income	-$23.36M	$3.54B	$681.19M	$347.60M
7 Day Performance	-2.05%	5.77%	1.42%	1.06%
1 Month Performance	-17.10%	10.11%	2.75%	0.81%
1 Year Performance	-71.68%	112.30%	199.68%	20.90%

TNF Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TNFA TNF Pharmaceuticals	N/A	$2.86 -1.0%	N/A	-72.0%	$5.28M	N/A	N/A	6
FOXX Foxx Development	1.2805 of 5 stars	$2.52 +0.8%	N/A	-61.9%	$17.60M	$59.54M	N/A	N/A	Analyst Downgrade Short Interest Decrease
EBON Ebang International	1.315 of 5 stars	$2.04 -1.4%	N/A	-48.5%	$13.55M	$6.54M	N/A	260	News Coverage Earnings Report
QCLS Mymd Pharmaceuticals	0.5947 of 5 stars	$2.89 +2.5%	N/A	N/A	$11.75M	N/A	N/A	6	Earnings Report
AIMD Ainos	0.4788 of 5 stars	$1.48 +3.5%	N/A	-62.8%	$10.56M	$13.60K	N/A	40	News Coverage Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TNFA) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TNF Pharmaceuticals (TNFA) Competitors

TNFA vs. FOXX, EBON, QCLS, AIMD, and AGMH

How does TNF Pharmaceuticals compare to Foxx Development?

Summary

How does TNF Pharmaceuticals compare to Ebang International?

Summary

How does TNF Pharmaceuticals compare to Mymd Pharmaceuticals?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Summary

How does TNF Pharmaceuticals compare to AGM Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNFA vs. The Competition

TNF Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TNF Pharmaceuticals (TNFA) Competitors

TNFA vs. FOXX, EBON, QCLS, AIMD, and AGMH

How does TNF Pharmaceuticals compare to Foxx Development?

Do institutionals and insiders believe in TNFA or FOXX?

Which has higher valuation & earnings, TNFA or FOXX?

Do analysts rate TNFA or FOXX?

Is TNFA or FOXX more profitable?

Which has more risk and volatility, TNFA or FOXX?

Does the media refer more to TNFA or FOXX?

Summary

How does TNF Pharmaceuticals compare to Ebang International?

Do insiders & institutionals have more ownership in TNFA or EBON?

Do analysts recommend TNFA or EBON?

Does the media refer more to TNFA or EBON?

Is TNFA or EBON more profitable?

Which has more risk & volatility, TNFA or EBON?

Which has higher earnings & valuation, TNFA or EBON?

Summary

How does TNF Pharmaceuticals compare to Mymd Pharmaceuticals?

Which has preferable earnings & valuation, QCLS or TNFA?

Do institutionals and insiders hold more shares of QCLS or TNFA?

Does the media favor QCLS or TNFA?

Which has more risk & volatility, QCLS or TNFA?

Is QCLS or TNFA more profitable?

Do analysts recommend QCLS or TNFA?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Do insiders & institutionals hold more shares of TNFA or AIMD?

Which has better valuation and earnings, TNFA or AIMD?

Does the media favor TNFA or AIMD?

Is TNFA or AIMD more profitable?

Do analysts rate TNFA or AIMD?

Which has more risk and volatility, TNFA or AIMD?

Summary

How does TNF Pharmaceuticals compare to AGM Group?

Does the media prefer AGMH or TNFA?

Do insiders and institutionals have more ownership in AGMH or TNFA?

Do analysts recommend AGMH or TNFA?

Is AGMH or TNFA more profitable?

Which has more risk and volatility, AGMH or TNFA?

Which has better earnings and valuation, AGMH or TNFA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNFA vs. The Competition

TNF Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools